Pinnacle Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-620,203
Closed -$738K 779
2022
Q3
$738K Sell
620,203
-82,501
-12% -$129K 0.02% 444
2022
Q2
$1.26M Sell
702,704
-3,512
-0.5% -$5.18K 0.03% 356
2022
Q1
$1.43M Sell
706,216
-120
-0% -$236 0.03% 388
2021
Q4
$1.91M Buy
706,336
+45,145
+7% +$167K 0.03% 358
2021
Q3
$2.95M Sell
661,191
-24,790
-4% -$119K 0.05% 282
2021
Q2
$3.98M Buy
685,981
+11,238
+2% +$65.8K 0.07% 243
2021
Q1
$4.74M Sell
674,743
-29,227
-4% -$196K 0.09% 215
2020
Q4
$3.38M Sell
703,970
-90,891
-11% -$460K 0.07% 240
2020
Q3
$4.63M Sell
794,861
-33,700
-4% -$202K 0.11% 192
2020
Q2
$5.59M Sell
828,561
-12,798
-2% -$96.9K 0.14% 163
2020
Q1
$5.35M Buy
841,359
+212,999
+34% +$1.71M 0.16% 149
2019
Q4
$6.55M Buy
+628,360
New +$4.57M 0.14% 166

Other funds holding CLVS